Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours

HER-2/neu oncoprotein contains several major histocompatibility complex class I-restricted epitopes, which are recognised by cytotoxic T lymphocyte (CTL) on autologous tumours and therefore can be used in immune-based cancer therapies. Of these, the most extensively studied is HER-2(9(369)). In the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sotiropoulou, P A, Perez, S A, Iliopoulou, E G, Missitzis, I, Voelter, V, Echner, H, Baxevanis, C N, Papamichail, M
Format:	Artigo
Language:	Inglês
Published:	Nature Publishing Group 2003
Subjects:	Molecular and Cellular Pathology
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2376937/ https://ncbi.nlm.nih.gov/pubmed/12966425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601244
Tags:	Add Tag No Tags, Be the first to tag this record!

Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours

Similar Items